Sintx Technologies Inc (SINT) Stock Price, Quote & News

Company Profile

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (P...

Industry: Medical Devices

Sector: Healthcare

Phone: 801 839 3500

Website: www.sintx.com

Address:

1885 West 2100 South, Salt Lake City, United States

Boston7452 Jul. 4 at 4:16 PM

$SINT Medtech should be suing Sintx mgmt/board for IP theft. Instead they get down adjusting warrants.

0 · Reply

Boston7452 Jul. 4 at 4:07 PM

$SINT issued new warrant to Medtech with full ratchet downward protection. Seriously contact SEC, Sintx is going to cost basis harvest again after it seems management gave away the manufacturing know how to Ned Medical to manufacture their Combisphere beads using Sintx material costings Sintx investors millions. "September 2025 warrant to purchase 760,881 shares will be cancelled and replaced with a new common stock purchase warrant to purchase 1,268,135 shares at $2.14 per share " "exercise price is subject to full-ratchet downward adjustment in any dilutive equity financing"

1 · Reply

Boston7452 Jul. 3 at 12:57 AM

$SINT what would have happened if Zimmer Biomet & Sintx, then Amedica, announced they were working on a hip implant together when this PR was released? https://www.biospace.com/amedica-announces-results-of-independent-femoral-head-wear-testing

0 · Reply

Boston7452 Jun. 30 at 10:49 PM

$SINT it’s going on 5 years since Sintx first hinted about its new PPE & Woundcare partner(s) with no news on who it is or whats been developed. Why? Is it strategic for the partner or was it done to help keep Sintx undervalued?

0 · Reply

Boston7452 Jun. 30 at 7:41 PM

$SINT Are we ever going to talk about this snoop? How’d you know?

0 · Reply

TaxiTravisBickle Jun. 30 at 4:41 PM

$AMDA “Classic”

0 · Reply

BillionerOfKing Jun. 30 at 3:49 AM

$SINT Current Stock Price: $1.86

0 · Reply

Boston7452 Jun. 29 at 1:51 AM

$SINT this pos scam has worked with Biomet on and off since 2005 or so with someone tied to Zimmer on its board since founding. Technology could do a lot of good if management would get out of the way.

1 · Reply

TAman87 Jun. 28 at 8:45 PM

$SINT this pos has been a scam since its ipo. Nothing to see here. Only a pump And dump Penny stock money printing operation with one sole pumper that has been here since 2015 pumping people to 0

0 · Reply

Boston7452 Jun. 27 at 9:30 PM

$SINT Nope Mr. Disinformation. Let’s talk how you knew about Varian Medical and when Sint became a short?

0 · Reply

Sintx Technologies Registration statement: Registration filing

2026-06-25T10:05:39.000Z - 9 days ago

Sintx Technologies files to sell 5.82M shares of common stock for holders

2026-06-22T14:00:56.000Z - 12 days ago

Sintx Technologies receives $3.2M in purchase orders

Jun 22, 2026, 9:00 AM EDT - 12 days ago

SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders

Jun 15, 2026, 11:13 AM EDT - 19 days ago

Sintx Technologies Transcript: Transcript

2026-06-04T11:45:10.000Z - 4 weeks ago

Sintx Technologies resumed with a Buy at Maxim

Jun 3, 2026, 9:00 AM EDT - 4 weeks ago

SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

May 17, 2026, 3:30 PM EDT - 6 weeks ago

SINTX Technologies to Present at the LD Micro Invitational XVI Conference

2026-04-13T10:11:23.000Z - 2 months ago

Sintx Technologies initiated with a Buy at H.C. Wainwright

Mar 23, 2026, 9:15 AM EDT - 3 months ago

SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

2026-03-19T11:51:39.000Z - 3 months ago

Sintx Technologies announces first in-human surgery using FDA-cleared Sinaptic

Mar 19, 2026, 7:30 AM EDT - 3 months ago

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

2026-02-18T13:40:31.000Z - 4 months ago

Sintx Technologies appoints Elmore as President

Feb 18, 2026, 8:30 AM EST - 4 months ago

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

Jan 29, 2026, 9:00 AM EST - 5 months ago

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

2025-12-01T13:35:45.000Z - 7 months ago

Sintx Technologies signs supply agreement with EVONIK

Dec 1, 2025, 8:30 AM EST - 7 months ago

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

2025-11-13T13:05:19.000Z - 8 months ago

Sintx Technologies reports Q3 EPS ($3.46) vs ($6.96) last year

Nov 13, 2025, 7:00 AM EST - 8 months ago

Sintx Technologies Earnings release: Q3 2025

2025-11-03T13:05:41.000Z - 8 months ago

Sintx Technologies announces launch of OsseoSculpt

Nov 3, 2025, 8:00 AM EST - 8 months ago

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

2025-10-23T20:40:36.000Z - 9 months ago

Sintx Technologies files to sell 1.74M shares of common stock for holders

2025-10-20T11:05:38.000Z - 9 months ago

Sintx receives FDA clearance for SINAPTIC Foot, Ankle implant system

Oct 20, 2025, 7:00 AM EDT - 9 months ago

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

2025-10-14T11:11:00.000Z - 9 months ago

Sintx Technologies announces U.S. patent notice of allowance

Oct 14, 2025, 7:00 AM EDT - 9 months ago

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

2025-09-30T20:55:10.000Z - 9 months ago

Sintx Technologies files to sell 541,450 shares of common stock for holders

2025-09-09T02:54:00.000Z - 10 months ago

Why Is Sintx Technologies Stock (SINT) Down 20% Today?

2025-09-08T12:01:04.000Z - 10 months ago

Sintx Technologies announces exercise of warrants for $3.8M gross proceeds

Sep 8, 2025, 7:54 AM EDT - 10 months ago

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

2025-09-08T11:25:37.000Z - 10 months ago

Sintx Technologies receives USPTO notice of allowance

Sep 8, 2025, 7:00 AM EDT - 10 months ago

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

2025-09-03T11:10:22.000Z - 10 months ago

Sintx Technologies publishes study of antiviral activity of Silicon Nitride

2025-08-15T11:11:47.000Z - 11 months ago

Sintx Technologies issues business update following strategic realignment

Aug 15, 2025, 7:00 AM EDT - 11 months ago

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

2025-08-04T11:20:10.000Z - 11 months ago

Sintx expands silicon nitride platform into hybrid CFR-PEKK trauma plates

Aug 4, 2025, 7:00 AM EDT - 11 months ago

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

Jun 24, 2025, 8:30 AM EDT - 1 year ago

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

May 22, 2025, 7:00 AM EDT - 1 year ago

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

May 15, 2025, 7:05 AM EDT - 1 year ago

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

May 15, 2025, 7:00 AM EDT - 1 year ago

Sintx Technologies Earnings release: Q1 2025

Feb 26, 2025, 8:00 AM EST - 1 year ago

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Feb 20, 2025, 6:15 AM EST - 1 year ago

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

Feb 19, 2025, 6:00 AM EST - 1 year ago

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Nov 21, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

Nov 19, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Nov 18, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Announces Stock Repurchase Program

Nov 14, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

Oct 1, 2024, 8:00 AM EDT - 1 year ago

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Sep 20, 2024, 8:00 AM EDT - 1 year ago

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

Sep 9, 2024, 8:00 AM EDT - 1 year ago

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Jun 18, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies to Explore Strategic Opportunities

Jun 12, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

Jun 6, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

May 23, 2024, 9:00 AM EDT - 2 years ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

Apr 29, 2024, 9:14 AM EDT - 2 years ago

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

Apr 3, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

Mar 29, 2024, 4:00 PM EDT - 2 years ago

SINTX Technologies Announces Proposed Public Offering of Common Stock

Mar 25, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Feb 21, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

Feb 2, 2024, 2:33 PM EST - 2 years ago

SINTX Technologies Announces Closing of $4.0 Million Public Offering

Jan 31, 2024, 9:20 AM EST - 2 years ago

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

Jan 30, 2024, 4:01 PM EST - 2 years ago

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

Jan 23, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

Jan 4, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

Nov 7, 2023, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Oct 11, 2023, 9:00 AM EDT - 2 years ago

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

Aug 17, 2023, 9:00 AM EDT - 3 years ago

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

Feb 10, 2023, 1:52 PM EST - 3 years ago

SINTX Technologies Announces Closing of $12.0 Million Public Offering

Feb 7, 2023, 9:05 PM EST - 3 years ago

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

Jan 19, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

Boston7452 Jul. 4 at 4:16 PM

$SINT Medtech should be suing Sintx mgmt/board for IP theft. Instead they get down adjusting warrants.

0 · Reply

Boston7452 Jul. 4 at 4:07 PM

1 · Reply

Boston7452 Jul. 3 at 12:57 AM

0 · Reply

Boston7452 Jun. 30 at 10:49 PM

0 · Reply

Boston7452 Jun. 30 at 7:41 PM

$SINT Are we ever going to talk about this snoop? How’d you know?

0 · Reply

TaxiTravisBickle Jun. 30 at 4:41 PM

$AMDA “Classic”

0 · Reply

BillionerOfKing Jun. 30 at 3:49 AM

$SINT Current Stock Price: $1.86

0 · Reply

Boston7452 Jun. 29 at 1:51 AM

1 · Reply

TAman87 Jun. 28 at 8:45 PM

$SINT this pos has been a scam since its ipo. Nothing to see here. Only a pump And dump Penny stock money printing operation with one sole pumper that has been here since 2015 pumping people to 0

0 · Reply

Boston7452 Jun. 27 at 9:30 PM

$SINT Nope Mr. Disinformation. Let’s talk how you knew about Varian Medical and when Sint became a short?

0 · Reply

SnoopyDog Jun. 27 at 7:04 PM

$SINT lol sure. Its you

0 · Reply

Boston7452 Jun. 27 at 6:12 PM

$SINT Lets talk about this Snoop since all you seem to want to talk about is the intention to cost basis harvest which we know is very lucrative. My 11k investment turned into ~60m loss which will offset alot of future capital gains tax. So I get why they may want to do that again. Hopefully the SEC & FBI intervenes beforehand.

0 · Reply

Boston7452 Jun. 27 at 3:14 PM

$SINT Not someone random. They posted only a few posts and only on Sintx board. They seemed to have no agenda. It could have been someone working for/representing Mr Kipke, but that’s the same thing imo.

1 · Reply

SnoopyDog Jun. 27 at 4:25 AM

$SINT lol this is an unverified random dude on stocktwits, probably you.looooool

1 · Reply

Boston7452 Jun. 26 at 6:17 PM

$SINT I wonder if Arthur Karl Kipke of Medtech, Sintx largest investor, knew about Varian Medical back in September of 2025? Its unlikely that Varian didnt spend months examining the tech so its likely.

0 · Reply

Boston7452 Jun. 26 at 5:23 PM

$SINT Just a matter of time before the SEC & FBI are investigating here.

0 · Reply

Boston7452 Jun. 26 at 5:03 PM

$SINT the fact that Sintx laid out probable intention to invest in Ned Medical in Oct and the CIO purchased over 100k shares in December, followed by Varian Medical's investment in Ned Medical in January, suggests they knew about Varian by December at the latest. Thus something happened in December that caused Sintx to bow out of investment and the transfer of IP to Ned Medical. Now if Sintx mgmt/board were not part of this, they should be very pissed...especially Honingblum who just bought over 100k shares. They should be going after Ned Medical in addition to just Dr Bock and they arent. The fact they arent is telling. The fact they are not going after Ned Medical to try to stop them from using the trade secrets they illegally obtained says to me they are on board with Ned Medical having those trade secrets. Going after Dr Bock looks like cover, using him as the obvious scapegoat, and the compensating him later.

0 · Reply

Boston7452 Jun. 26 at 3:25 PM

$SINT you see snoop I think you did know something big was coming (Varian Medical) and then you knew plans had changed (thus flipped short). Last time mgmt really bought shares (CIO purchased 100k shares) was in December. Not including the small amount of shares a few board members purchased in Feb/March. Odd that board would buy a few thousand shares just before suing Dr Bock.

1 · Reply

Boston7452 Jun. 26 at 2:59 PM

$SINT but I think we should talk about this Snoop because it looks like you’ve given us a timeline of around when Sintx leadership decided to steal Sintx IP and give it to Ned Medixal for their benefit later. I’m sure they all intend to invest in Ned Medical in the future.

0 · Reply

Boston7452 Jun. 26 at 2:55 PM

$SINT it doesn’t have to be highly diluted if the board and management are removed. Sintx has very important and valuable IP. It just needs the right stewardship. This buy shares, remove board/fire mgmt. However Sintx has a lot of methods for mgmt to protect themselves and board thus SEC & FBI are needed. Class action lawsuits against board/mgmt are needed as well.

0 · Reply

1BigWoody Jun. 26 at 1:10 PM

$SINT rough out here.

0 · Reply

The_Gambl3r Jun. 26 at 12:25 PM

$SINT hmmmmm 👀

0 · Reply

Market Cap	8.21M
Revenue (ttm)	1.02M
Net Income (ttm)	-10.36M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,015.69%
Debt to Equity Ratio	0.12

Volume	21,000
Avg Vol	56,478
Day's Range	N/A - N/A
Shares Out	4.32M
Stochastic %K	29%
Beta	0.63
Analysts	Sell
Price Target	$11.00